Adaptimmune Therapeutics PLC (ADAP)
1.08
-0.06
(-5.26%)
USD |
NASDAQ |
Apr 24, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Market Cap: 266.57M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 266.57M |
| April 23, 2024 | 281.38M |
| April 22, 2024 | 249.29M |
| April 19, 2024 | 241.07M |
| April 18, 2024 | 221.75M |
| April 17, 2024 | 243.62M |
| April 16, 2024 | 254.23M |
| April 15, 2024 | 259.17M |
| April 12, 2024 | 286.32M |
| April 11, 2024 | 318.40M |
| April 10, 2024 | 313.47M |
| April 09, 2024 | 338.15M |
| April 08, 2024 | 335.68M |
| April 05, 2024 | 338.15M |
| April 04, 2024 | 333.21M |
| April 03, 2024 | 340.62M |
| April 02, 2024 | 345.56M |
| April 01, 2024 | 362.83M |
| March 28, 2024 | 389.98M |
| March 27, 2024 | 389.98M |
| March 26, 2024 | 375.17M |
| March 25, 2024 | 355.43M |
| March 22, 2024 | 355.43M |
| March 21, 2024 | 330.75M |
| March 20, 2024 | 328.28M |
| Date | Value |
|---|---|
| March 19, 2024 | 348.02M |
| March 18, 2024 | 362.83M |
| March 15, 2024 | 365.30M |
| March 14, 2024 | 360.36M |
| March 13, 2024 | 392.45M |
| March 12, 2024 | 367.77M |
| March 11, 2024 | 380.11M |
| March 08, 2024 | 431.94M |
| March 07, 2024 | 429.48M |
| March 06, 2024 | 422.07M |
| March 05, 2024 | 360.36M |
| March 04, 2024 | 365.30M |
| March 01, 2024 | 361.20M |
| February 29, 2024 | 356.65M |
| February 28, 2024 | 365.74M |
| February 27, 2024 | 388.46M |
| February 26, 2024 | 372.56M |
| February 23, 2024 | 336.21M |
| February 22, 2024 | 313.49M |
| February 21, 2024 | 340.75M |
| February 20, 2024 | 286.23M |
| February 16, 2024 | 272.60M |
| February 15, 2024 | 283.96M |
| February 14, 2024 | 290.78M |
| February 13, 2024 | 271.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
76.25M
Minimum
Nov 15 2019
1.750B
Maximum
Jun 04 2020
481.90M
Average
357.71M
Median
Mar 30 2020
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 3.288M |
| NuCana PLC | 8.119M |
| Autolus Therapeutics PLC | 1.120B |
| Mereo BioPharma Group PLC | 389.92M |
| TC BioPharm (Holdings) PLC | 4.697M |
Market Cap Related Metrics
| PS Ratio | 3.606 |
| Price to Book Value | 6.746 |
| Price | 1.08 |
| Earnings Yield | -43.87% |